Virtus ETF Advisers’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,037
| Closed | -$327K | – | 626 |
|
|
2024
Q4 | $327K | Buy |
9,037
+622
| +7% | +$22.5K | 0.13% | 232 |
|
|
2024
Q3 | $270K | Hold |
8,415
| – | – | 0.13% | 238 |
|
|
2024
Q2 | $317K | Sell |
8,415
-2,572
| -23% | -$96.9K | 0.16% | 220 |
|
|
2024
Q1 | $541K | Buy |
10,987
+1,581
| +17% | +$77.8K | 0.29% | 169 |
|
|
2023
Q4 | $343K | Buy |
9,406
+5,816
| +162% | +$212K | 0.22% | 193 |
|
|
2023
Q3 | $83K | Sell |
3,590
-356
| -9% | -$8.23K | 0.05% | 354 |
|
|
2023
Q2 | $103K | Sell |
3,946
-368
| -9% | -$9.65K | 0.06% | 366 |
|
|
2023
Q1 | $111K | Sell |
4,314
-1,664
| -28% | -$42.8K | 0.06% | 330 |
|
|
2022
Q4 | $155K | Buy |
5,978
+827
| +16% | +$21.5K | 0.08% | 334 |
|
|
2022
Q3 | $147K | Buy |
5,151
+40
| +0.8% | +$1.14K | 0.06% | 355 |
|
|
2022
Q2 | $126K | Buy |
5,111
+2,823
| +123% | +$69.6K | 0.05% | 368 |
|
|
2022
Q1 | $129K | Sell |
2,288
-137
| -6% | -$7.72K | 0.06% | 250 |
|
|
2021
Q4 | $150K | Sell |
2,425
-215
| -8% | -$13.3K | 0.06% | 348 |
|
|
2021
Q3 | $167K | Sell |
2,640
-134
| -5% | -$8.48K | 0.07% | 317 |
|
|
2021
Q2 | $229K | Sell |
2,774
-1,232
| -31% | -$102K | 0.09% | 244 |
|
|
2021
Q1 | $295K | Buy |
4,006
+66
| +2% | +$4.86K | 0.12% | 243 |
|
|
2020
Q4 | $286K | Sell |
3,940
-3,228
| -45% | -$234K | 0.12% | 232 |
|
|
2020
Q3 | $342K | Sell |
7,168
-981
| -12% | -$46.8K | 0.18% | 193 |
|
|
2020
Q2 | $342K | Sell |
8,149
-4,299
| -35% | -$180K | 0.16% | 273 |
|
|
2020
Q1 | $336K | Sell |
12,448
-1,805
| -13% | -$48.7K | 0.14% | 214 |
|
|
2019
Q4 | $549K | Buy |
+14,253
| New | +$549K | 0.09% | 198 |
|